Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Acura Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 80.56% |
| September 30, 2021 | -97.04% |
| June 30, 2021 | -63.13% |
| March 31, 2021 | -40.22% |
| December 31, 2020 | -33.84% |
| September 30, 2020 | -165.4% |
| June 30, 2020 | 22.80% |
| March 31, 2020 | -54.54% |
| December 31, 2019 | 12.70% |
| September 30, 2019 | 15.11% |
| June 30, 2019 | -7.26K% |
| March 31, 2019 | -1.18K% |
| December 31, 2018 | 12.70% |
| September 30, 2018 | -1.50K% |
| June 30, 2018 | -1.66K% |
| March 31, 2018 | -754.5% |
| December 31, 2017 | -2.35K% |
| September 30, 2017 | -2.65K% |
| June 30, 2017 | -2.34K% |
| March 31, 2017 | 14.91% |
| December 31, 2016 | 40.74% |
| September 30, 2016 | -1.03K% |
| June 30, 2016 | -1.28K% |
| March 31, 2016 | -1.51K% |
| December 31, 2015 | -34.19% |
| Date | Value |
|---|---|
| September 30, 2015 | -1.26K% |
| June 30, 2015 | -780.9% |
| March 31, 2015 | 23.13% |
| December 31, 2014 | -509.6% |
| September 30, 2014 | -2.00K% |
| June 30, 2014 | -10.06K% |
| March 31, 2014 | -9.73K% |
| December 31, 2013 | -9.76K% |
| September 30, 2013 | -3.84K% |
| June 30, 2013 | -307.6K% |
| March 31, 2013 | -105.4K% |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | 84.16% |
| March 31, 2011 | -1.23K% |
| December 31, 2010 | -815.3% |
| September 30, 2010 | -874.3% |
| June 30, 2010 | -514.8% |
| March 31, 2010 | -197.8% |
| December 31, 2009 | -544.5% |
| September 30, 2009 | -489.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.26K%
Minimum
Jun 2019
80.56%
Maximum
Dec 2021
-689.6%
Average
-40.22%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |